Paired molecular testing of amniotic fluid and fetal ventricular cerebrospinal fluid for Toxoplasma gondii and cytomegalovirus in severe fetal hydrocephalus: a descriptive case series

Abstract Background Severe fetal hydrocephalus has heterogeneous structural, genetic, hemorrhagic, and infectious causes. Amniotic-fluid molecular testing is established for suspected cytomegalovirus (CMV) and Toxoplasma gondii infection, whereas testing of fetal ventricular cerebrospinal fluid (CSF) obtained during cephalocentesis is rarely reported. Methods In this single-centre descriptive cross-sectional case series, nine pregnant women carrying fetuses with severe or progressive hydrocephalus underwent clinically indicated cephalocentesis at RSAB Harapan Kita, Jakarta, from March to July 2026. Paired amniotic-fluid and ventricular-CSF specimens underwent real-time PCR for T. gondii and CMV; maternal IgG, IgM, and IgG avidity were also assessed. Data were summarized descriptively, with exact binomial 95% confidence intervals for zero-detection proportions. Results Median maternal age was 31 years (26–36) and gestational age was 30.71 weeks (21.57–36.71). Neither pathogen was detected in amniotic fluid or ventricular CSF (0/9 for each pathogen in each compartment; exact 95% CI 0–33.6%). T. gondii IgG was positive in 5/9, IgM was negative in 9/9, and avidity was high in all five IgG-positive participants. CMV IgG was positive in 9/9, IgM was negative in 9/9, and avidity was high in 9/9. Median ventricular-CSF volume was 40 mL (30–50). Posterior ventricular width decreased from 35.35 to 25.61 mm immediately after aspiration (median decrease 8.21 mm, range 2.72–26.44), a descriptive anatomical observation. Delivery outcomes were available for seven pregnancies; all were live births by caesarean delivery, while two pregnancies remained ongoing. Conclusions In this small selected series, paired testing found no molecular evidence of T. gondii or CMV in either fetal compartment, and maternal serology did not support recent primary infection. A negative ventricular-CSF PCR should not be treated as a validated rule-out test. Prenatal infection testing should use amniotic fluid and be interpreted with maternal serology and fetal imaging; this series does not support cephalocentesis solely to detect infection.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-16
DOI
https://doi.org/10.21203/rs.3.rs-11200217/v1
Primary Topic
Toxoplasma gondii Research Studies
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Paired molecular testing of amniotic fluid and fetal ventricular cerebrospinal fluid for Toxoplasma gondii and cytomegalovirus in severe fetal hydrocephalus: a descriptive case series

Damar Prasmusinto, Mohammad Adya Firmansha Dilmy, Yuditiya Purwosunu, Noroyono Wibowo et al.
Research Square
Toxoplasma gondii Research Studies
preprint

Paired molecular testing of amniotic fluid and fetal ventricular cerebrospinal fluid for Toxoplasma gondii and cytomegalovirus in severe fetal hydrocephalus: a descriptive case series

Damar Prasmusinto, Mohammad Adya Firmansha Dilmy, Yuditiya Purwosunu, Noroyono Wibowo, Yudianto Budi Saroyo, Rima Irwinda, Agustina Nurmala, Gatot Abdurrazak
preprint en

Abstract

Abstract Background Severe fetal hydrocephalus has heterogeneous structural, genetic, hemorrhagic, and infectious causes. Amniotic-fluid molecular testing is established for suspected cytomegalovirus (CMV) and Toxoplasma gondii infection, whereas testing of fetal ventricular cerebrospinal fluid (CSF) obtained during cephalocentesis is rarely reported. Methods In this single-centre descriptive cross-sectional case series, nine pregnant women carrying fetuses with severe or progressive hydrocephalus underwent clinically indicated cephalocentesis at RSAB Harapan Kita, Jakarta, from March to July 2026. Paired amniotic-fluid and ventricular-CSF specimens underwent real-time PCR for T. gondii and CMV; maternal IgG, IgM, and IgG avidity were also assessed. Data were summarized descriptively, with exact binomial 95% confidence intervals for zero-detection proportions. Results Median maternal age was 31 years (26–36) and gestational age was 30.71 weeks (21.57–36.71). Neither pathogen was detected in amniotic fluid or ventricular CSF (0/9 for each pathogen in each compartment; exact 95% CI 0–33.6%). T. gondii IgG was positive in 5/9, IgM was negative in 9/9, and avidity was high in all five IgG-positive participants. CMV IgG was positive in 9/9, IgM was negative in 9/9, and avidity was high in 9/9. Median ventricular-CSF volume was 40 mL (30–50). Posterior ventricular width decreased from 35.35 to 25.61 mm immediately after aspiration (median decrease 8.21 mm, range 2.72–26.44), a descriptive anatomical observation. Delivery outcomes were available for seven pregnancies; all were live births by caesarean delivery, while two pregnancies remained ongoing. Conclusions In this small selected series, paired testing found no molecular evidence of T. gondii or CMV in either fetal compartment, and maternal serology did not support recent primary infection. A negative ventricular-CSF PCR should not be treated as a validated rule-out test. Prenatal infection testing should use amniotic fluid and be interpreted with maternal serology and fetal imaging; this series does not support cephalocentesis solely to detect infection.

Research Square
University of Indonesia (ID)
Good health and well-being
Toxoplasma gondii Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon